shouldiuse.io

Categories

VERDICT

De Novo Software (FCS Express) Review

Depends

Should I use De Novo Software (FCS Express)?

Skip to content - denovosoftware.com

· 1 month ago

Buy if you run a flow or image cytometry core, clinical lab, or pharma team needing validated analysis with e-signatures and permission controls. Skip if you only gate a few plots occasionally. Free viewers and cloud tools will do.

Confidence

Medium. Based on 30+ public sources; thin on independent user reviews and published pricing.

Ratings

  • Value for moneyNo public pricing evidence
  • Ease of useNo independent usability reviews found
  • Feature depth
  • Support quality
  • Security posture

Pricing

Quote-only

Commercial

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
AcademicDiscounted, quote-only

Best for

  • Flow cytometry core facilities
  • Clinical labs needing e-signatures and audit controls
  • Pharma/biotech R&D teams
  • Image cytometry users (PerkinElmer, ChemoMetec compatibility)

Not for

  • Students doing one-off gating, free viewers suffice
  • Anyone analyzing non-cytometry data
  • Buyers needing published prices before contacting sales
  • Teams without Windows/SQL Server admin capacity

Gotchas - check before you buy

medium

Quote-based pricing hides real cost until you talk to sales; academic discounts require eligibility verification.

medium

Permission/security features need MS SQL Server configuration, budget admin time before rollout.

medium

Licenses phone home to De Novo servers; connection failures can block the app.

low

Free Reader only views files. Real analysis still needs a paid license.

Pros and cons

Pros

  • Handles flow and image cytometry data in one package
  • Regulated-lab controls: electronic signatures and permission rules
  • Pipelines feature automates repetitive analysis workflows
  • Bundled by instrument vendors like Cytek and ChemoMetec
  • Free FCS Express Reader lets collaborators view shared files

Cons

  • No public pricing; sales contact required for any quote
  • License activation requires connecting to De Novo servers
  • Windows desktop app; SQL Server setup for security features
  • Third-party scanners rate the site 0/100 trust
  • Very few independent user reviews found in public sources

Sources & method

- 11 sources - Vendor publishes a security page and ships e-signature/permission tooling; third-party scanners flag the domain 0/100 trust, likely niche-site noise rather than confirmed issues.

official x3review x2security x2news x4
  • Third-party trust scanners score domain 0/100, OffSeq Guard and similar scanners rate 0/100; no confirmed vulnerabilities disclosed in the sources.

Key stats

  • Feature depth: 5/5

    Rating

  • Quote-only

    Starting price

  • 11

    Sources

  • Analyzed

  • Value for money. No public pricing evidence
  • Ease of use. No independent usability reviews found
  • Feature depth: 5/5. Pipelines, e-signatures, permission rules, image cytometry
  • Support quality: 4/5. Deep FAQ knowledge base, vendor-run demos at university cores
  • Security posture: 3/5. Strong product controls; third-party scanners flag domain trust 0/100
  • FCS Express 7 Latest version Vendor consolidating V7 editions
  • Quote-only Pricing No prices published; contact support/sales
  • Cytek, ChemoMetec, Partec Instrument partners Bundle FCS Express with hardware
  • 0/100 Domain trust score OffSeq/Guard third-party scan

Pricing

Commercial

Quote-only

  • Contact sales for pricing
  • Windows desktop license

Academic

Discounted, quote-only

  • Eligibility verification required
  • Contact sales

Security

Vendor publishes a security page and ships e-signature/permission tooling; third-party scanners flag the domain 0/100 trust, likely niche-site noise rather than confirmed issues.

  • Third-party trust scanners score domain 0/100OffSeq Guard and similar scanners rate 0/100; no confirmed vulnerabilities disclosed in the sources.11

What users say

Independent user reviews are scarce; most commentary comes from academic citations and vendor-partner materials, not practicing users.

Alternatives

Compare De Novo Software (FCS Express) with each alternative.

Full analysis

Based on 30+ public sources; thin on independent user reviews and published pricing.

Serious flow cytometry software for labs; quote-only pricing and desktop setup make it overkill for casual users.

Methodology

Based on 30+ public sources; thin on independent user reviews and published pricing.

Read how a report is made.

Sources

  1. De Novo Software - Crunchbase Company Profilecrunchbase.com
    news
  2. Cytek Biosciences Adds De Novo Software to Lineup of Advanced Flow Cytometry Systemsglobenewswire.com
    news
  3. ChemoMetec and De Novo Software to Co-market NucleoCounter and FCS Express Image Cytometrybiospace.com
    news
  4. FCS Express: What's New with Pipelines (UCSF Flow Core)flow.ucsf.edu
    news
  5. FCS Express Reviews - Slashdotslashdot.org
    review
  6. FCS Express Reviews - SourceForgesourceforge.net
    review
  7. Prices - De Novo Softwaredenovosoftware.com
    official
  8. Academic Pricing - De Novo Softwaredenovosoftware.com
    official
  9. Electronic signature FAQ - De Novo Softwaredenovosoftware.com
    official
  10. Product security page - De Novo Softwaredenovosoftware.com
    security
  11. Trust score analysis - OffSeq Guardguard.offseq.com
    security

Add this review to your site

This check for De Novo Software (FCS Express) says Depends.

Put the badge on your site.

Visitors see the independent review.

The link points here, and search engines follow it.

This is the badge visitors see on your site.

Depends De Novo Software (FCS Express) Independent review on Should I Use It

Paste one snippet. Keep the link as it is. A nofollow tag stops search engines from following it.

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.